financetom
Business
financetom
/
Business
/
BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin
Aug 25, 2025 6:38 AM

Aug 25 (Reuters) - Abbvie Inc ( ABBV ):

* ABBVIE TO ACQUIRE GILGAMESH PHARMACEUTICALS' BRETISILOCIN,

A

NOVEL, INVESTIGATIONAL THERAPY FOR MAJOR DEPRESSIVE DISORDER,

EXPANDING PSYCHIATRY PIPELINE

* ABBVIE INC ( ABBV ) - TO BUY BRETISILOCIN PROGRAM FOR UP TO $1.2

BILLION

* ABBVIE ( ABBV ) - GILGAMESH WILL SPIN OFF A NEW ENTITY THAT WILL

OPERATE

UNDER NAME GILGAMESH PHARMA INC

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved